Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S ADR (NY: NVO )

141.96 +0.97 (+0.69%)
Official Closing Price Updated: 4:10 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Novo Nordisk A/S ADR

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
48 49 Next >
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,600 Today
Via Benzinga
3 Top Growth Stocks I'd Buy Right Now Without Hesitation
These drugmakers are all leaders in their respective niches. 
Via The Motley Fool
Is It Time to Take Some Gains in Novo Nordisk Stock? Not So Fast.
Novo Nordisk stock has been on a tear, but the company's latest financial report suggests it may just be getting started. 
Via The Motley Fool
(NVO) - Analyzing Novo Nordisk's Short Interest
Via Benzinga
How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment
The company tested its drug, Wegovy, in patients with a common form of heart failure. 
Via Investor's Business Daily
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
Novo Nordisk A/S's (NYSE: NVO) CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's (NYSE: CTLT) capability to rectify its manufacturing issues related to its  
Via Benzinga
These Three New Markets May Propel Novo Nordisk's Ozempic To Greater Heights
Via Benzinga
Looking At Novo Nordisk's Recent Unusual Options Activity
Via Benzinga
Ozempic Just Got Even Better for Novo Nordisk Stock
A new study suggests that it could be useful for a gargantuan new indication. 
Via The Motley Fool
WeWork's Journey From $47B Valuation To Possible Bankruptcy, Mastercard and Visa Reassess Ties with Binance Card, Hawaiian Electric Accused Of Jeopardizing Investigation Of Maui Wildfires: Today's Top Stories
Wall Street Journal 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Novo Nordisk's Weight Loss Treatment Shows Benefit In Patients With Most Common Type Of Heart Failure
Novo Nordisk A/S (NYSE: NVO) announced resul 
Via Benzinga
Novo Nordisk Eyes Social Inequality To Enhance Access To Wegovy: 'Have To Be More Intentional'
Via Benzinga
This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks Soaring
Some of their winning medicines could soon compete in new markets. 
Via The Motley Fool
Live Off The Fat Of The Land With These Two Stocks
These two pharmaceutical companies will turn into massive money-making machines. 
Via Talk Markets
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
It'll take some time to try to enter those markets, but the upside could be huge. 
Via The Motley Fool
Why Novo Nordisk Stock Was Racing Higher on Wednesday
When you have a hot item on the market, it's wise to ramp up production. 
Via The Motley Fool
Airbnb Versus New York Regulations, Netflix Adds New US Users After Password Crackdown, Facebook Marketplace Under Regulatory Fire For Alleged Sale Of Recalled Items: Top Stories
Wall Street Journal Airbnb Versus New York: What's Going On? 
Via Benzinga
One Is Not Enough For Famed Weight Loss Drug: Novo Nordisk Taps Thermo Fisher To Ramp Up Wegovy Production
Novo Nordisk A/S (NYSE: NVO) has reportedly enlisted the services of Thermo Fisher Scientific Inc (NYSE: TMO) as its second contract manufacturer for its highly sought-after  
Via Benzinga
Denmark Mulls Changes To Diabetes Drug Subsidies: A Closer Look At Weight Loss Drug Debate
A public commission in Denmark has recommended the cessation of subsidies for GLP-1 drugs, including Ozempic and similar medications, as a primary treatment for type 2 diabetes.  
Via Benzinga
Looking for the Next Big Biopharma Stock? These 4 Letters Are 1 Big Clue Where to Find It
NASH is a surprisingly common ailment, and the first treatments are on the way. 
Via The Motley Fool
Could This 1 Problem Put a Dent in Novo Nordisk and Eli Lilly Stock?
Chasing indications for NASH has been a pitfall for many pharma companies. 
Via The Motley Fool
Gold Rush In Weight Loss Industry Impacts Retailers With Pharmacy Businesses
Retailers with pharmacy businesses, including major players like Walmart Inc (NYSE: WMT), Kroger Company (NYSE: KR), and Rite Aid Corp (NYSE: 
Via Benzinga
Benzinga Buzz: Kim Denies Ozempic Use, But Not Tracy Morgan. Plus: Hurricane Hilary
Each week, Benzinga Buzz compiles the latest entertainment news into a cohesive column for your consideration. Read on for the latest updates — both useful and irreverent. 
Via Benzinga
3 Fantastic Stocks to Buy in a New Bull Market
These stocks could be just the ticket if a sustained new bull market is beginning. 
Via The Motley Fool
Obesity Crisis Costs US $200B Annually, But Arrival Of Treatments Signal Declining Surgery Demands
With an annual toll of $200 billion due to health complications like diabetes and heart disease, the surging obesity crisis has adversely impacted Americans regarding health and the economy. However,... 
Via Benzinga
Topics Economy
Exposures Economy
Famed Weight Loss Drugs - Medications Far Pricier In US Than Other Developed Countries
A recent health policy organization KFF analysis highlighted that weight-loss drugs are considerably pricier in the U.S. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Blue Shield of California Ends CVS Caremark Partnership, Google's Verily Life Sciences Intensifies Cost-Cutting, Tesla's Autopilot Under Fire Again: Today's Top Stories
Wall Street Journal 
Via Benzinga
Why This Nugget Of Bad Weight-Loss News Isn't Weighing On Lilly, Novo
Prescription trends data for July showed a slight decrease, but there's still room to run. 
Via Investor's Business Daily
7 A-Rated Biotech Stocks for Your August Buy List
Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge. 
Via InvestorPlace
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.